Status:
COMPLETED
Evaluation Of Clinical Pharmacy Services in Patients Receiving Antithrombotic Treatment
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Cardiovascular Diseases
Drug Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Clinical pharmacy services aim to enhance patient outcomes and reduce the risk of potential drug-related harm by offering patient-centred pharmaceutical care. In the hospital setting, clinical pharmac...
Detailed Description
Patients with cardiovascular disease are at significant risk for adverse drug events and medication errors. Moreover, the rate of use of high-risk drugs such as antithrombotic drugs is higher in these...
Eligibility Criteria
Inclusion
- Being 18 years and older.
- Receiving antithrombotic treatment.
- Having complete biochemical and complete blood count values collected at least twice, with two-day medication information fully entered into the hospital system.
- Patients who could be evaluated by the clinical pharmacist for at least 24 hours within the intervention group.
Exclusion
- Being under 18 years old.
- Not using antithrombotic medication.
- Patients whose biochemical and complete blood count values were not collected twice and whose two-day medication information was not fully recorded in the hospital system.
- Patients in the intervention group whom the clinical pharmacist did not see for at least 24 hours (weekend hospital admission followed by Monday morning discharge, Friday admission with weekend discharge, etc.) were excluded from the study.
Key Trial Info
Start Date :
November 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06193473
Start Date
November 30 2021
End Date
November 30 2022
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakıf Üniversitesi
Istanbul, Fatih, Turkey (Türkiye), 34096